First Allied Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
CFGS
RJA
MCM
SPIA
First Allied Advisory Services's IHE Position: Q3 2020 in Review
First Allied Advisory Services reduced its iShares US Pharmaceuticals ETF (IHE) stake by 7.3% in Q3 2020, selling an estimated $16.2K and leaving 3,786 shares worth $206K. The position accounts for 0.01% of the portfolio, ranked #1058.
First Allied Advisory Services first reported a position in IHE in Q1 2015 and has held it in 23 quarters since. The position peaked at $478K in Q3 2018. 94 funds tracked by Wall St. Rank hold IHE as of Q3 2020.
- First Allied Advisory Services held 3,786 shares of iShares US Pharmaceuticals ETF worth $206K as of Q3 2020.
- First Allied Advisory Services sold 300 iShares US Pharmaceuticals ETF shares in Q3 2020, an estimated $16.2K.
- iShares US Pharmaceuticals ETF made up 0.01% of First Allied Advisory Services's portfolio in Q3 2020, its #1058 holding.
- First Allied Advisory Services first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and has held it in 23 quarters since.
- First Allied Advisory Services's iShares US Pharmaceuticals ETF position peaked at $478K in Q3 2018.
- 94 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2020.
Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.